Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(365)
•••
Post by NothinButTimeon Jul 19, 2020 2:33pm
173 Views
Post# 31287923

LGC acquires Natuve Antigen Company

LGC acquires Natuve Antigen Company

https://www.lgcgroup.com/newsroom-and-blog/news-and-blog/lgc-acquires-nac/

"We recently celebrated our 175th anniversary, with a 2-day international conference organised in London as well as with an internal emerging scientist conference, showcasing the breadth, depth and impact of the work we undertake, as well as how much our scientists, established and emerging, are leading in their fields of application."

"Our origins can be traced back to 1842 when the Laboratory of the Board of Excise was founded in the City of London to regulate the adulteration of tobacco which was prohibited under the Pure Tobacco Act."
 

"Since privatisation, we have significantly expanded our activities. Employee numbers have risen from 270 in 1996 to over 2,300 in 2020, as we have grown organically and through multiple acquisitions."
 

https://www.lgcgroup.com/about-us/about-lgc/


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities